Cellbxhealth and Solaris Health. Will parsortix be used in12 May 2026 13:24
Cancer detection trials to get approval for Worldwide use? The aim was an assay to detect clinically significant prostate cancer with high specificity and sensitivity, reducing the need for unnecessary, invasive tissue biopsies. They started looking into this in 2022. Is this what the 2nr. trials are for??
====================
"Key Aspects of the Parsortix-based Test for Solaris Health:Purpose: The goal was to develop an assay to detect clinically significant prostate cancer with high specificity and sensitivity, reducing the need for unnecessary, invasive tissue biopsies.Target Population: Solaris Health, a major U.S. urology group, provided access to a large patient base across various prostate cancer disease states, including pre-prostate biopsy, post-negative biopsy, active surveillance, and metastatic disease.Technology: The system isolates intact, living CTCs from the blood using a microfluidic cascade, allowing for both identification and downstream molecular analysis to determine the cancer’s aggressiveness.Initial Study: The partnership initiated a study with 100 men,, where blood samples were processed at ANGLE's US clinical laboratory to compare the results with conventional tissue biopsies.This partnership aims to use the Parsortix system to provide a non-invasive way to monitor prostate cancer through repeatable blood draws, addressing the shortcomings of the conventional prostate-specific antigen (PSA) test.".
Sign In
Follow the stocks
